We are live on ! Find out more
LTAS

Linden Thomas Advisory Services Portfolio holdings

AUM $1.24B
1-Year Est. Return 47.37%
This Fund
S&P 500
This Quarter Est. Return
+28.86%
1 Year Est. Return
+47.37%
3 Year Est. Return
+135.71%
5 Year Est. Return
10 Year Est. Return
AUM
$1.24B
AUM Growth
+$202M
Cap. Flow
+$29.1M
Cap. Flow %
2.35%
Top 10 Hldgs %
14.48%
Holding
552
New
22
Increased
322
Reduced
196
Closed
10

Top Buys

Rank Stock Value
1
SITM icon
SiTime
SITM
+$2.74M
2
MCHP icon
Microchip Technology
MCHP
+$2.06M
3
OTTR icon
Otter Tail
OTTR
+$1.94M
4
P
Everpure Inc
P
+$1.91M
5
GSL icon
Global Ship Lease
GSL
+$1.74M

Sector Composition

Rank Sector Weight
1 Technology 35.67%
2 Industrials 14.81%
3 Healthcare 12.31%
4 Financials 9.32%
5 Consumer Discretionary 8.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRAI icon
101
CRA International
CRAI
$1.1B
$3.3M 0.27%
23,207
+2,474
+12% +$372K
GD icon
102
General Dynamics
GD
$105B
$3.27M 0.26%
9,236
+417
+5% +$143K
GRMN
103
Garmin
GRMN
$46.9B
$3.25M 0.26%
13,663
+358
+3% +$87.1K
SITM icon
104
SiTime
SITM
$16.6B
$3.24M 0.26%
+4,341
New +$2.74M
ORCL icon
105
Oracle
ORCL
$331B
$3.23M 0.26%
22,069
+750
+4% +$136K
NTAP icon
106
NetApp
NTAP
$32.9B
$3.23M 0.26%
20,872
+522
+3% +$68.2K
WTS icon
107
Watts Water Technologies
WTS
$11.5B
$3.23M 0.26%
8,248
+886
+12% +$276K
MRK icon
108
Merck
MRK
$324B
$3.23M 0.26%
25,106
+582
+2% +$68.1K
QCOM icon
109
Qualcomm
QCOM
$176B
$3.22M 0.26%
17,411
+934
+6% +$175K
FORM icon
110
FormFactor
FORM
$8.11B
$3.21M 0.26%
20,077
-19,951
-50% -$2.65M
REGN icon
111
Regeneron Pharmaceuticals
REGN
$68.8B
$3.18M 0.26%
5,106
-16
-0.3% -$10.9K
PINS icon
112
Pinterest
PINS
$12.4B
$3.18M 0.26%
151,024
+3,689
+3% +$74.1K
KNX icon
113
Knight Transportation
KNX
$11.8B
$3.17M 0.26%
40,753
+1,039
+3% +$72K
EXEL icon
114
Exelixis
EXEL
$13.9B
$3.15M 0.25%
57,943
+34,486
+147% +$1.68M
NBIX icon
115
Neurocrine Biosciences
NBIX
$17.7B
$3.15M 0.25%
18,676
+11,215
+150% +$1.66M
LOW icon
116
Lowe's Companies
LOW
$116B
$3.14M 0.25%
14,252
+516
+4% +$117K
LGND icon
117
Ligand Pharmaceuticals
LGND
$6.02B
$3.14M 0.25%
9,935
-6,734
-40% -$1.59M
INTU icon
118
Intuit
INTU
$81.1B
$3.14M 0.25%
12,028
+155
+1% +$54K
ENTG icon
119
Entegris
ENTG
$19.7B
$3.11M 0.25%
17,298
-106
-0.6% -$15.3K
REZI icon
120
Resideo Technologies
REZI
$5.23B
$3.08M 0.25%
98,892
+10,813
+12% +$372K
MCHP icon
121
Microchip Technology
MCHP
$42.8B
$3.07M 0.25%
33,679
+23,084
+218% +$2.06M
ORLY icon
122
O'Reilly Automotive
ORLY
$72.4B
$3.07M 0.25%
33,308
-98
-0.3% -$8.94K
NSSC icon
123
Napco Security Technologies
NSSC
$1.28B
$3.06M 0.25%
80,539
+8,067
+11% +$320K
ASTH icon
124
Astrana Health
ASTH
$2B
$3.06M 0.25%
65,893
+7,218
+12% +$260K
AMGN icon
125
Amgen
AMGN
$203B
$3.03M 0.24%
8,364
+224
+3% +$76.7K

Similar funds

Linden Thomas Advisory Services's Q2 2026 Portfolio in Review

As of Q2 2026, Linden Thomas Advisory Services held 552 positions worth $1.24B, up 19% from $1.04B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Linden Thomas Advisory Services's Q2 2026 filing shows 22 new, 322 increased, 196 reduced and 10 closed positions. Its largest new stake was SiTime: 4,341 shares worth $3.24M. The largest sale was Globalstar, an estimated $3.7M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 30% a quarter earlier, followed by Industrials and Healthcare.

  • Linden Thomas Advisory Services's largest Q2 2026 buy was SiTime: 4,341 shares worth $3.24M.
  • Linden Thomas Advisory Services added most to Microchip Technology in Q2 2026, an estimated $2.06M increase.
  • Linden Thomas Advisory Services's biggest Q2 2026 reduction was Globalstar, cutting an estimated $3.7M.
  • Linden Thomas Advisory Services fully exited Solventum in Q2 2026, selling an estimated $1.78M.
  • Linden Thomas Advisory Services's ten largest holdings make up 14% of its $1.24B portfolio in Q2 2026.
  • Linden Thomas Advisory Services opened 22 new positions and closed 10 in Q2 2026.
  • Linden Thomas Advisory Services's portfolio value rose 19% quarter-over-quarter to $1.24B.

Based on Linden Thomas Advisory Services's 13F filing for Q2 2026, filed 16 Jul 2026.